Target intelligence / Profile preview

Thiosulfate sulfurtransferase-like domain-containing protein 3 (TSTD3)

Target
TSTD3
Molecular classification
Enzyme (predicted), Rhodanese domain-containing protein, Sulfurtransferase superfamily (putative)
01

Overview

Thiosulfate sulfurtransferase-like domain-containing protein 3 (TSTD3) is a predicted protein in humans and other vertebrates that contains a single rhodanese-like domain. Unlike classic thiosulfate sulfurtransferases, TSTD3 lacks a critical catalytic cysteine residue necessary for sulfurtransferase activity, and is therefore not expected to catalyze conventional sulfur transfer reactions[2]. Its specific biological role is unknown; there is no current evidence associating it with disease, therapeutic targeting, or physiological processes[2][3]. It is classified within the sulfurtransferase/rhodanese superfamily by sequence homology but awaits experimental characterization. Key distinctions: TSTD3 appears to be a structurally related, but functionally divergent, member of the sulfurtransferase family and is not predicted to function as an active sulfurtransferase enzyme[2]. No evidence supports TSTD3 as a therapeutic target, receptor, or biomarker at this time[2][3]. Note: TSTD3 should not be confused with thiosulfate sulfurtransferase (TST), also known as rhodanese, which is enzymatically active and clinically relevant[1][2].

Other names
Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3TSTD3Rhodanese domain-containing protein 3thiosulfate sulfurtransferase (rhodanese)-like domain containing 3
02

Mechanism of action

None established; function as a classical sulfurtransferase is unlikely due to lack of catalytic cysteine in the active site[2].

03

Biological functions

Unknown; no validated enzymatic or physiological function in humans[2][3].Likely involved in sulfur metabolism based on domain homology[2].Potential for protein-protein sulfur relay inferred from related family members[2].
04

Disease associations

Unknown; no clear disease association reported[3].No evidence for clinical or pathological involvement available.
05

Safety considerations

None reported; no established therapeutic targeting or known toxicity.
06

Interacting drugs

None reported; no drugs are known to selectively interact with TSTD3.
07

Biomarkers

None reported; TSTD3 is not established as a biomarker for any disease or therapy.

Beyond the preview

Go deeper on Thiosulfate sulfurtransferase-like domain-containing protein 3 (TSTD3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thiosulfate sulfurtransferase-like domain-containing protein 3 (TSTD3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call